{
    "nct_id": "NCT03542695",
    "official_title": "Use of 64Cu-DOTA-Alendronate PET Imaging for Localization and Characterization of Breast Calcifications",
    "inclusion_criteria": "* Evidence of calcifications on mammogram\n* Biopsy confirmed malignancy associated calcifications in at least one breast\n* Biopsy confirmed benign calcifications in at least one breast (same or contralateral breast)\n* Planned total mastectomy for treatment\n* Ability to provide informed consent\n* Negative serum pregnancy test\n* No evidence of impaired hepatic or kidney function\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participants who do not have residual calcifications present on mammogram following biopsy\n* Concurrent malignancy other than non-melanoma skin cancer\n* Patients with known metastatic disease\n* Patients who have received prior treatment for the current breast cancer\n* Patients currently using oral bisphosphonate therapy\n* Patients with injection of other radioactive material within 90 days\n* Inability to provide informed consent\n* Pregnant or lactating patients\n* Patients with impaired kidney function (creatinine >= 1.3 mg/dL or < 0.6 mg/dL)",
    "miscellaneous_criteria": ""
}